Biofil Chemicals & Pharmaceuticals informs about disclosure

22 Feb 2023 Evaluate
In terms of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosures Requirements) Regulations, 2015 as amended, Biofil Chemicals & Pharmaceuticals has informed that its Registrar and Share Transfer Agent i.e., Ankit Consultancy has duly completed the process of sending intimation via email on 10th February, 2023 to the Members of the Biofil Chemicals And Pharmaceuticals pertaining to SEBI Circular No. SEBI/HO/OIAE/2023/03391dated January 27, 2023 read together with SEBI /HO/ MIRSD/MIRSD_RTAMB/P/CIR/2022/76 dated May 30, 2022 regarding availability of Dispute Resolution Mechanism at Stock Exchanges against Company/Registrar to an Issue and Share Transfer Agents (RTA). Summary of the aforesaid communications is being made available on website at: www.biofilgroup.net under Investors Section.

The above information is a part of company’s filings submitted to BSE.

Biofil Chem & Pharma Share Price

68.50 2.65 (4.02%)
14-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1545.25
Dr. Reddys Lab 5861.00
Cipla 1356.95
Zydus Lifesciences 984.75
Lupin 1635.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.